Is There Still a Role for Cyclosporine in the Treatment of Inflammatory Bowel Disease? Pro Argument
Open Access
- 1 May 2003
- journal article
- review article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 9 (3) , 194-197
Abstract
I found the title of this episode of Controversies in IBD—“Is There Still a Role for Cyclosporine in the Treatment of Inflammatory Bowel Disease? Pro Argument”—a bit perplexing. When did cyclosporine (CSA) ever cease to have a role in inflammatory bowel disease (IBD)? Is one to suppose that the surgery for ulcerative colitis (UC) has become so refined that all patients undergoing surgery for severe colitis are rendered “cured” of their chronic intestinal ailments? Or should we believe that, despite the lack of controlled trial evidence in severe UC, infliximab has already become an acceptable alternative to cyclosporine or surgery? For patients with severe UC who do not benefit from steroid treatment, both randomized controlled trial data and extensive open-label experience demonstrate the consistent efficacy of CSA, albeit at a stiff cost. For patients with the far less frequent Crohn's disease (CD) who do not benefit from any medical therapy, including infliximab, and are confronted with limited surgical options, CSA clearly remains an important option as well.Keywords
This publication has 22 references indexed in Scilit:
- Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitisGastroenterology, 2001
- Long-term outcome of treatment with cyclosporine IV for patients with intractable ulcerative colitisGastroenterology, 2001
- Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitisAmerican Journal of Gastroenterology, 2000
- Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitisAlimentary Pharmacology & Therapeutics, 2000
- Intravenous Cyclosporin in Ulcerative Colitis: A Five-Year ExperienceAmerican Journal of Gastroenterology, 1999
- Efficacy and Efficiency of Oral Microemulsion Cyclosporin Versus Intravenous and Soft Gelatin Capsule Cyclosporin in the Treatment of Severe Steroid-Refractory Ulcerative Colitis: An Open-Label Retrospective TrialInflammatory Bowel Diseases, 1998
- Intravenous cyclosporin as rescue therapy in severe ulcerative colitisEuropean Journal of Gastroenterology & Hepatology, 1998
- Effectiveness of cyclosporine a (CsA) in the treatment of active refractory ulcerative colitis (UC)Gastroenterology, 1998
- Predicting outcome in severe ulcerative colitis.Gut, 1996
- Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid TherapyNew England Journal of Medicine, 1994